Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology

Area of Science:

• Neuroscience
• Metabolic Disorders
• Pathology

Background:

• Alzheimer's Disease (AD) and Type 2 Diabetes (T2D) share risk factors and pathological pathways, particularly involving insulin signaling.
• Dysfunctional insulin/PI3K/Akt signaling is implicated in both T2D and AD, suggesting a common mechanistic link.

Purpose of the Study:

• To investigate how T2D influences AD pathology and cognitive function using a novel T2D model.
• To elucidate the molecular mechanisms underlying the interaction between T2D and amyloid-beta (Aβ) in the brain.

Main Methods:

• A T2D model was created by combining streptozotocin (STZ) with a high-fat diet (HJF) in rodents.
• Intracerebroventricular infusion of amyloid-beta 42 (Aβ42) was used to mimic AD pathology.
• Spatial recognition memory and hippocampal protein expression related to signaling, autophagy, inflammation, and glucose uptake were assessed.

Main Results:

• The T2D model exhibited hyperglycemia, insulin dysfunction, and memory deficits.
• Aβ42 infusion alone caused transient memory deficits and protein deregulation.
• Combined T2D and Aβ42 exacerbated and prolonged memory deficits, inducing significant changes in autophagy, inflammation, and glucose uptake proteins.

Conclusions:

• T2D creates a neuronal environment that worsens AD pathology and cognitive decline when amyloid-beta is present.
• Parallel neuronal insults from T2D facilitate the development of AD-like pathological events and memory impairments.
• Environmental enrichment showed potential for transiently improving memory and reversing some protein alterations.